Henry Schein's (HSIC) Q1 Earnings, Revenues Beat Estimates
Henry Schein, Inc. HSIC reported adjusted earnings per share (EPS) from continuing operations of 80 cents in the first quarter of 2019, up 8.1% year over year. Adjusted EPS beat the Zacks Consensus Estimate by 5.3% on revenue growth across global Medical and Technology and Value-added Services businesses.
On a reported basis, EPS from continuing operations came in at 78 cents, an 8.3% improvement on a year-over-year basis.
Revenues in Detail
Henry Schein reported net sales of $2.36 billion in the first quarter, up 3.8% year over year. The metric exceeded the Zacks Consensus Estimate by 0.9%. The year-over-year improvement came on the back of 4.3% internal sales growth in local currencies along with acquisition growth of 2.3%. The top line was adversely impacted by 2.8% from unfavorable foreign currency exchange.
...
https://finance.yahoo.com/news/henry-sch...05419.html
Henry Schein, Inc. HSIC reported adjusted earnings per share (EPS) from continuing operations of 80 cents in the first quarter of 2019, up 8.1% year over year. Adjusted EPS beat the Zacks Consensus Estimate by 5.3% on revenue growth across global Medical and Technology and Value-added Services businesses.
On a reported basis, EPS from continuing operations came in at 78 cents, an 8.3% improvement on a year-over-year basis.
Revenues in Detail
Henry Schein reported net sales of $2.36 billion in the first quarter, up 3.8% year over year. The metric exceeded the Zacks Consensus Estimate by 0.9%. The year-over-year improvement came on the back of 4.3% internal sales growth in local currencies along with acquisition growth of 2.3%. The top line was adversely impacted by 2.8% from unfavorable foreign currency exchange.
...
https://finance.yahoo.com/news/henry-sch...05419.html
![[Bild: HSICc1dl1638.png]](https://finviz.com/publish/050719/HSICc1dl1638.png)
__________________